The Position We are seeking a highly motivated Scientist/Sr. Scientist/Principal Scientist to join our Mass Spectrometry based Biomarker team within the Drug Discovery Sciences (DDS) department in Germany. Youu2019ll work at the cutting edge of drug discovery - shaping breakthrough therapies and making an immediate impact. In this role, you will represent your scientific discipline in cross-functional teams, advance cutting-edge methods in proteomics, mass spectrometry, and molecular sciences. You will help shape u201cfirstu2011inu2011classu201d opportunities across our discovery portfolio and contribute to a culture of scientific excellence. At the Sr. Scientist/Principal Scientist levels significant responsibilities in project leadership and supervision of technical and scientific staff or scientific leadership of peers is expected. Tasks & responsibilities In your new role, you will scientifically review requests for biomarker discovery & quantitation, will align the purpose and path-forward with our partners in project teams Lead the design, execution, and analysis of proteomics experiments, including Biomarker discovery, targeted quantification, PTM identification, or interactome determination. Expertise in operating cutting-edge mass spectrometry platforms (Orbitrap, QTOF, etc.) and expert understanding of respective analysis software. You will be using Omics-platforms for translational topics, NTC confirmation, functional validation and MoA elucidation in alignment with our research & development partners. You have high interest in innovative approaches, challenge the u2018status quou2019 and will further advance the scientific and proteomics workflows Additional tasks are to educate and train Boehringer Ingelheim colleagues in proteomic analysis and to continue to develop scientific and drug development expertise The Sr./Principal Scientist may lead a team of technicians and/or MSc/PhD students and/or interns and/or Postdocs. The Sr./Principal Scientist will be a team representative in discovery projects, guides scientific/technological development and implementation of concepts in respective areas. The Principal Scientist will independently drive innovations, lead the development and implementation of cross-functional strategies/initiatives to advance projects. Requirements PhD in the field of mass spectrometry-based proteomics, biochemistry or pharmacology Sr./Principal scientist - experienced scientist with multiyear drug discovery and (matrix) leadership/supervisor and discovery project representative experience. Experience with state-of-the-art proteomics workflows, ideally applying data-independent acquisition (DIA) workflows on a Thermo orbitrap Astral mass spectrometer. Experience in sample preparation from cells and tissues for LC-MS analyses is required. Analytical mindset, with a keen interest in advancing proteomic methodologies and the ability to work independently and collaboratively in an interdisciplinary research environment. Conceptual understanding of biomarkers in drug discovery and development is an asset Solid understanding of biochemistry, molecular mechanisms, and pharmacology relevant to drug discovery. Critical and creative thinking, self-motivated to innovate. Excellent data analysis and data management skills, as well as presentation skills. Fluent written and spoken English and German(a plus) If you are a highly motivated and experienced scientist with a passion for biomarker research and translational sciences, we invite you to apply for this opportunity. Join our team and contribute to the development of innovative therapies that improve patients' lives. Ready to contact us? If you have any questions about the job posting or process - please contact our HR Direct TeamTel: 49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com Recruitment process: Step 1: Online application - The job posting is presumably online until March 17th, 2026. We reserve the right to take the posting offline beforehand. Applications up to March 11th, 2026 are guaranteed to be considered. Step 2: Virtual meeting in end of March 2026. Step 3: On-site interviews end of March 2026. All qualified applicants will receive consideration for employment without regard to a personu2019s actual or perceived race, including natural hairstyles, hair texture and protective hairstyles; color; creed; religion; national origin; age; ancestry; citizenship status, marital status; gender, gender identity or expression; sexual orientation, mental, physical or intellectual disability, veteran status; pregnancy, childbirth or related medical condition; genetic information (including the refusal to submit to genetic testing) or any other class or characteristic protected by applicable law.